オプションチェーンは、Intl Land Allianceの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Intl Land Allianceの市場センチメントを評価します。.

Intl Land Alliance (OTC:ILAL) 株価情報, オプションチェーン

International Land Alliance Inc is a residential land development company with target properties located in the Baja California, Norte region of Mexico. Its activities include purchasing properties, obtaining zoning and other entitlements required to subdivide the properties into residential and commercial building plots, securing financing for the purchase of the plots, improving the property's infrastructure and amenities, and selling the plots to homebuyers, retirees, investors, and commercial developers. The Company's real estate portfolio includes Oasis Park Resort, Valle Divino in Ensenada, Plaza Bajamar Resort which is part of Bajamar Oceanfront hotel and Golf Resort, Emerald Grove Estates in Southern California, and lastly Rancho Costa Verde, on Baja California's east coast.

INTERNATIONAL LAND ALLICE by International Land Alliance Inc.

International Land Alliance Inc

<p>JP Morgan  analyst Jeffrey Zekaukas   maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Overweight and raises the price target from $110 to $112.</p>


News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Eastman Chemical, Raises Price Target to $112

<p><strong>LyondellBasell Industries N.V.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) reported better-than-expected fourth-quarter 2024 <a href="https://www.benzinga.com/quote/lyb/earnings">sales on Friday</a>.</p>
<p>LyondellBasell reported revenues of $9.497 billion, down 4.4% year-over-year and above the consensus of $9.225 billion. Adjusted EPS was at 75 cents, which is in-line with the consensus.</p>
<p>"The volumes of our sustainable products are rapidly growing and aligned with our profitability targets. We are sharpening our focus on value creation while diligently managing and tracking our progress through a highly disciplined Value Enhancement Program. With a robust investment-grade balance sheet, LYB is well-positioned to deliver on our strategic promises and reward shareholders with a growing dividend as part of our overall value proposition," commented LyondellBasell CEO Peter Vanacker.</p>
<p>For 2025, the company said it anticipates seasonal demand improvements in the first quarter of 2025, supported by lower interest rates, moderate inflation, and rising durable goods consumption.</p>
<p>The company aligns operations with global demand, expecting Olefins &amp; Polyolefins Americas at 80%, EAI at 75% and Intermediates &amp; Derivatives at 80%.</p>
<p>LyondellBasell shares fell 0.2% to trade at $75.53 on Monday.</p>
<p>These analysts made changes to their price targets on LyondellBasell following earnings announcement.</p>
<ul>
<li>Wells Fargo analyst Michael Sison maintained LyondellBasell with an Overweight and lowered the price target from $95 to $90.</li>
<li>UBS analyst Joshua Spector maintained LyondellBasell with a Neutral and lowered the price target from $77 to $76.</li>
<li>Barclays analyst Michael Leithead maintained the stock with an Equal-Weight and cut the price target from $90 to $80.</li>
</ul>
<p><strong>Considering buying LYB stock? Here&#8217;s what analysts think: </strong></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="601" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-1024x601.png" alt="" class="wp-image-763207" style="width:537px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-1024x601.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-768x451.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1.png 1101w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields"><strong>Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</strong></a></li>
</ul>


Earnings

Trading Ideas

These Analysts Slash Their Forecasts On LyondellBasell Industries After Q4 Results

<p>JP Morgan  analyst Melissa Wedel   maintains Carlyle Secured Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBD#NASDAQ">CGBD</a>) with a Underweight and raises the price target from $16 to $17.</p>


CGBD

JP Morgan Maintains Underweight on Carlyle Secured Lending, Raises Price Target to $17

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>AbbVie</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 24 uncommon options trades for AbbVie.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 25% bullish and 50%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $105,465, and 21 are calls, for a total amount of $1,655,712.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $210.0 for AbbVie over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $150.0 to $210.0 in the last 30 days. </p>
<h3>AbbVie Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738607428_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$4.7</td>
<td>$4.55</td>
<td>$4.56</td>
<td>$195.00</td>
<td>$615.5K</td>
<td align="right">546</td>
<td>1.4K</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$15.5</td>
<td>$14.2</td>
<td>$15.3</td>
<td>$175.00</td>
<td>$84.1K</td>
<td align="right">225</td>
<td>171</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$16.1</td>
<td>$14.6</td>
<td>$15.15</td>
<td>$175.00</td>
<td>$83.3K</td>
<td align="right">225</td>
<td>61</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$10.9</td>
<td>$10.1</td>
<td>$10.1</td>
<td>$180.00</td>
<td>$77.7K</td>
<td align="right">529</td>
<td>22</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/07/25</td>
<td>$16.85</td>
<td>$16.2</td>
<td>$16.58</td>
<td>$172.50</td>
<td>$72.9K</td>
<td align="right">200</td>
<td>45</td>
</tr>
</tbody>
</table>
</p>
<h3>About AbbVie</h3>
<p>AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).</p>
<p>Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of AbbVie</h3>
<ul>
<li>Trading volume stands at 4,545,253, with ABBV's price up by 3.15%, positioned at $189.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 81 days.</li>
</ul>
<h3>What Analysts Are Saying About AbbVie</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $208.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Raymond James has revised its rating downward to Outperform, adjusting the price target to $220.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on AbbVie with a target price of $190.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $211.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $205.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on AbbVie with a target price of $217. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for AbbVie, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

ABBV

Looking At AbbVie's Recent Unusual Options Activity

<p>High-rolling investors have positioned themselves bullish on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in DHR often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 13 options trades for Danaher. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 61% bullish and 38% bearish. Among all the options we identified, there was one put, amounting to $26,400, and 12 calls, totaling $9,798,273.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $240.0 for Danaher, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Danaher stands at 1815.33, with a total volume reaching 6,881.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Danaher, situated within the strike price corridor from $220.0 to $240.0, throughout the last 30 days.</p>
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738607423_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$28.6</td>
<td>$27.3</td>
<td>$28.6</td>
<td>$240.00</td>
<td>$7.8M</td>
<td>2.5K</td>
<td>3.4K</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$30.1</td>
<td>$26.5</td>
<td>$29.9</td>
<td>$240.00</td>
<td>$299.0K</td>
<td>2.5K</td>
<td>0</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$29.6</td>
<td>$27.4</td>
<td>$29.6</td>
<td>$240.00</td>
<td>$296.0K</td>
<td>2.5K</td>
<td>300</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$29.4</td>
<td>$28.3</td>
<td>$29.4</td>
<td>$240.00</td>
<td>$294.0K</td>
<td>2.5K</td>
<td>630</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$29.4</td>
<td>$28.2</td>
<td>$29.4</td>
<td>$240.00</td>
<td>$294.0K</td>
<td>2.5K</td>
<td>510</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<p>After a thorough review of the options trading surrounding Danaher, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of Danaher</h3>
<ul>
<li>Currently trading with a volume of 2,405,344, the DHR's price is down by -2.51%, now at $217.16. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 78 days.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $256.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Jefferies persists with their Buy rating on Danaher, maintaining a target price of $260.<br />
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Danaher, which currently sits at a price target of $258.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Danaher with a target price of $240.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Danaher, which currently sits at a price target of $240.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on Danaher, maintaining a target price of $285. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Danaher with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Danaher's Options: A Look at What the Big Money is Thinking

<p>Financial giants have made a conspicuous bullish move on RH. Our analysis of options history for RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) revealed 15 unusual trades.</p>
<p>Delving into the details, we found 40% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $404,855, and 7 were calls, valued at $397,165.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $125.0 to $600.0 for RH over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of RH stands at 126.6, with a total volume reaching 554.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in RH, situated within the strike price corridor from $125.0 to $600.0, throughout the last 30 days.</p>
<h3>RH 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738607418_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$3.7</td>
<td>$3.3</td>
<td>$3.7</td>
<td>$385.00</td>
<td>$104.7K</td>
<td align="right">70</td>
<td align="right">93</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$13.7</td>
<td>$13.1</td>
<td>$13.1</td>
<td>$390.00</td>
<td>$94.3K</td>
<td align="right">1</td>
<td align="right">149</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$31.0</td>
<td>$26.0</td>
<td>$31.0</td>
<td>$600.00</td>
<td>$93.0K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$14.8</td>
<td>$14.0</td>
<td>$14.1</td>
<td>$402.50</td>
<td>$70.1K</td>
<td align="right">0</td>
<td align="right">100</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$36.4</td>
<td>$35.5</td>
<td>$36.4</td>
<td>$350.00</td>
<td>$65.5K</td>
<td align="right">43</td>
<td align="right">18</td>
</tr>
</tbody>
</table>
</p>
<h3>About RH</h3>
<p>RH is a luxury furniture and lifestyle retailer operating in the $134 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 19 restaurant locations. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in bespoke furniture, architecture, media, and more.</p>
<p>In light of the recent options history for RH, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>RH's Current Market Status</h3>
<ul>
<li>Trading volume stands at 592,123, with RH's price down by -3.92%, positioned at $402.68.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 51 days.</li>
</ul>
<h3>What Analysts Are Saying About RH</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $473.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays upgraded its action to Overweight with a price target of $515.<br />
&#x2A; In a positive move, an analyst from Morgan Stanley has upgraded their rating to Overweight and adjusted the price target to $530.<br />
&#x2A; Showing optimism, an analyst from Goldman Sachs upgrades its rating to Neutral with a revised price target of $374. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest RH options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


RH's Options: A Look at What the Big Money is Thinking

<p>JP Morgan  analyst Puneet Jain   maintains Broadridge Financial Soln (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) with a Neutral and raises the price target from $231 to $249.</p>


JP Morgan Maintains Neutral on Broadridge Financial Soln, Raises Price Target to $249

WIIM

HWKN

Hawkins shares are trading higher after the company announced the acquisition of Amerochem Corporation.

<p>JP Morgan  analyst Melissa Wedel   maintains Blackstone Secured (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXSL#NYSE">BXSL</a>) with a Overweight and raises the price target from $33 to $33.5.</p>


BXSL

JP Morgan Maintains Overweight on Blackstone Secured, Raises Price Target to $33.5

<p>JP Morgan  analyst Melissa Wedel   maintains Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) with a Overweight and raises the price target from $23 to $24.5.</p>


ARCC

JP Morgan Maintains Overweight on Ares Capital, Raises Price Target to $24.5

China's UN Envoy Says We Need Cooperation On AI, Particularly Between China, U.S., Fragmentation Will Only Enhance Risk And Reduce Benefits

E.L.F. Beauty shares are trading lower after Stifel cut its price target on the stock from $115 to $105.

<p><strong>Olin Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) reported upbeat results for its fourth quarter, after the <a href="https://www.benzinga.com/quote/OLN/earnings">closing bell on Thursday</a>.</p>
<p>The company posted quarterly earnings of 9 cents per share which beat the analyst consensus estimate of a loss of 3 cents per share. The company reported quarterly sales of $1.671 billion which beat the analyst consensus estimate of $1.549 billion.</p>
<p>Ken Lane, President, and Chief Executive Officer, said, &#8220;While we expect challenging industry conditions to continue into 2025, we will stay focused on optimizing our core businesses through our value-first commercial approach as well as controlling our costs as we described during our Investor Day in December. We remain confident in our ability to generate higher trough-level earnings and cash flow despite the difficult environment.&#8221;</p>
<p>Olin shares fell 5.1% to trade at $27.81 on Monday.</p>
<p>These analysts made changes to their price targets on Olin following earnings announcement.</p>
<ul>
<li>Keybanc analyst Aleksey Yefremov maintained Olin with an Overweight and lowered the price target from $50 to $40.</li>
<li>Wells Fargo analyst Michael Sison maintained Olin with an Equal-Weight and lowered the price target from $40 to $31.</li>
<li>Truist Securities analyst Peter Osterland maintained the stock with a Hold and cut the price target from $38 to $32.</li>
<li>Barclays analyst Michael Leithead maintained the stock with an Equal-Weight and slashed the price target from $43 to $34.</li>
</ul>
<p><strong>Considering buying OLN stock? Here&#8217;s what analysts think:</strong> </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="564" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132134/image-8-1024x564.png" alt="" class="wp-image-763201" style="width:574px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132134/image-8-1024x564.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132134/image-8-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132134/image-8-768x423.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132134/image-8.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></strong></li>
</ul>


These Analysts Cut Their Forecasts On Olin After Q4 Earnings

BOOT

Boot Barn shares are trading lower after UBS cut its price target on the stock from $210 to $200.

Polaris shares are trading lower after UBS cut its price target on the stock from $67 to $48.

PTCT

PTC Therapeutics shares are trading higher after Cantor Fitzgerald raised its price target on the stock from $76 to $113.

DOOO

TSX:DOO

BRP shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and cut its price target from C$90 to C$70.

<p>The Federal Reserve kept rates steady last week, citing the struggle against last-mile inflation and the potential of tariff shocks to influence prices. While Chairman Jerome Powell's news conference was relatively low key, it did contain notes of uncertainty and traders are betting that a March rate cut could be out of the picture.</p>
<p>Markets would still prefer lower rates, but steady rates combined with a deregulatory push from the new administration could benefit one sector in particular — banks.</p>
<p>The banking sector has posted significant gains since the November election results and if rates and tariffs are creating uncertainty, bank stocks could be a safe haven until markets have more clarity — and earn you some dividends income while you wait.&nbsp;</p>
<p><strong>Here are the four bank stocks to buy for the tariff and interest rate uncertainty.</strong></p>
<p>For banks, it's crucial to focus on certain fundamental metrics to find favorable stocks. If you're buying bank stocks based on regulatory tailwinds, using technical indicators like moving averages or momentum oscillators may align with long-term holding timeframes.</p>
<p>Instead, factors like Price-to-Book (P/B) ratio and Return on Equity (ROE) provide better clues. Additionally, net interest margin (NIM) is a crucial bank profitability metric since it measures the difference between interest paid on deposits and interest received on loans. NIM tends to decline when rates rise as lending conditions tighten, fewer loans are issued, and customer deposits earn higher interest. But when rates stay flat or decline, banking activity picks up, and NIM can grow.</p>
<p>A ‘good' NIM can fluctuate based on the size of the bank and the types of loans issued, but a bank with a negative NIM during a flat or declining rate environment could be in trouble.</p>
<p>For our selections here, we selected bank stocks showing a P/B ratio between 1.00 and 2.00, ROE above 9%, and NIM above the industry average of 3%.</p>
<h2 class="wp-block-heading">Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>)</h2>
<p>One of the oldest and biggest banks in America also has one of the most appealing stocks entering 2025. Bank of America gained more than 30% in 2024 and based on recent numbers, that momentum could continue. BAC has a $352 billion market cap and operates in all 50 states, specializing in personal and commercial banking, plus investment management, mortgage and brokerage services, wealth management, and a variety of market-making and lending operations.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="301" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131057/BAC-1-1024x301.png" alt="" class="wp-image-763186" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131057/BAC-1-1024x301.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131057/BAC-1-300x88.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131057/BAC-1-768x226.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131057/BAC-1.png 1303w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>BAC suffered a nearly 25% decline in July 2024, but has rebounded in the last few month and recently made a new all-time high, surpassing the previous mark of $46.31 set in January 2022. Bank of America currently has a 1.31 P/B value and a 9.2% ROE, with a forward P/E ratio of 10.65 and a dividend yield of 2.35%. BAC received two Buy ratings from Morgan Stanley and Opperheimer in January, along with a Hold reiteration from Piper Sandler. The average price target from these three is $53, indicating a potential upside of 15% from the January 31 closing price of $46.25.</p>
<h2 class="wp-block-heading">Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>)</h2>
<p>Goldman Sachs has dabbled in consumer banking, but its true focus in investment banking, wealth management, and market making. Goldman is one of the more prestigious Wall Street banks, serving individual, corporate, institutional, and governmental clients. The company currently has a $200 billion market cap and employs over 46,000 people.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="301" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131103/GS-1024x301.png" alt="" class="wp-image-763187" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131103/GS-1024x301.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131103/GS-300x88.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131103/GS-768x226.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131103/GS.png 1303w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>GS shares are up nearly 70% over the last 12 months, thanks in large part to significant revenue growth. The company has grown quarterly revenue 7.5% year-over-year, far surpassing our other bank stock picks and pushing the stock to new all-time highs at $650 per share. Goldman Sachs has a 1.88 P/B value and 12.4 forward P/E, indicating a slightly-elevated value, but the 12% ROE should assuage investors. The stock pays a 1.96% dividend yield and received two reiterated Buy ratings on January 16 from Morgan Stanley and Barclays with $782 and $760 respective price targets.</p>
<p>[GET A CHARTER MEMBER DISCOUNT TO ‘BENZINGA TRADE ALERTS'- <strong><a href="https://www.benzinga.com/premium/ideas/trade-alerts//?utm_source=WebRD-0204&amp;el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}">200 SPOTS ONLY</a></strong>]</p>
<h2 class="wp-block-heading">HSBC Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSBC#NYSE">HSBC</a>)</h2>
<p>We're heading across the pond for our next stock selection to London's HSBC Holdings, one of the largest and oldest banks in England (you might be sensing a theme). HSBC operates in three banking segments: Personal, Commercial, and Global and Markets. The bank has a $187 billion market cap and pays a handsome 7.95% dividend yield.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="301" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131107/HSBC-1024x301.png" alt="" class="wp-image-763188" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131107/HSBC-1024x301.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131107/HSBC-300x88.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131107/HSBC-768x226.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131107/HSBC.png 1303w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>The Bank of England currently has its prime rate set higher than the Federal Funds rate, but the institution is expected to drop that rate to 4.5% in the coming weeks. Falling rates aren't always good news for banks, but HSBC is positioned to absorb any shock thanks to 6.8% quarterly year-over-year revenue growth. The stock has a 0.99 P/B value and its current ROE is over 12%. The forward P/E of 8.36 also indicates an undervalued security.</p>
<h2 class="wp-block-heading">Bank of New York Mellon Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>)</h2>
<p>Bank of New York Mellon is the smallest entry on our list with a market cap of just over $17 billion. But while it lacks in size (at least compared to the heavy hitters listed above), its stock packs a punch. The bank was founded in New York City in 1784 and specializes in investment banking and wealth management, and offers its own securities through ETFs and mutual funds. Despite the smaller market cap, the company actually has more employees than Goldman with 52,000 full-time staff.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="301" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131115/BK-1024x301.png" alt="" class="wp-image-763189" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131115/BK-1024x301.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131115/BK-300x88.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131115/BK-768x226.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03131115/BK.png 1303w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>BK stock is already up 12% year-to-date after gaining more than 40% in 2024. In terms of valuation metrics, BK looks like Baby Bear's porridge — just right. The bank sports a 1.55 P/B value, right in between our guideline of 1% to 2%. It also tops 11% ROE and has a forward P/E of 11.3. While Bank of New York Mellon doesn't get the recognition of a Goldman Sachs or JPMorgan Chase, its been offering quality investment management services for nearly 150 years, and its stock has a promising outlook in 2025. Plus, the dividend yield is nearly 15% higher than what Goldman is offering.</p>
<p>Secure your discounted charter membership to the new ‘Benzinga Trade Alerts'- before Monday&#8217;s public launch. And start receiving weekly simple trade alerts targeting 150%, 237%, and 664% gains. <strong><a href="https://www.benzinga.com/premium/ideas/trade-alerts//?utm_source=WebRD-0204&amp;el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}">Secure Your Spot Here.</a></strong></p>
<p>Image Via Shutterstock</p>


Opinion

HSBC

4 Banks to Buy Ahead of Trump's Deregulatory Blitz

<p><a href="https://www.globenewswire.com/Tracker?data=Xpy7VNU5nu85v7KBykXeX2ye2a4w7mT6S8NPLlwrW6Lt9BVrla6XPNpTwNfWYsB3ue6INuyssPi7l66dJn61CWxSOXrIoYB-BURdcLDCeAg=">Red Cat Holdings, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, will host an Investor and Analyst Day on Thursday, February 27 from 11:00 a.m. - 1:00 p.m. eastern time at the Nasdaq MarketSite in New York City.</p>


Comments

Intl Land Alliance

Intl Land Alliance (ILAL) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル